Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 20/20 | 1.00 |
| ▸ | SRC | P12931 | 20/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 19/20 | 1.00 |
| ▸ | PIK3CA | P42336 | 19/20 | 1.00 |
| ▸ | PIK3CB | P42338 | 19/20 | 1.00 |
| ▸ | PIK3CG | P48736 | 19/20 | 1.00 |
| ▸ | PRKDC | P78527 | 19/20 | 1.00 |
| ▸ | EGFR | P00533 | 18/20 | 1.00 |
| ▸ | HCK | P08631 | 18/20 | 1.00 |
| ▸ | KDR | P35968 | 18/20 | 1.00 |
| ▸ | MTOR | P42345 | 18/20 | 1.00 |
| ▸ | EPHB4 | P54760 | 18/20 | 1.00 |
| ▸ | PI4KB | Q9UBF8 | 14/20 | 1.00 |
| ▸ | BACE1 | P56817 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3609552 | 0.88 | SRC (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL3607753 | 0.86 | PIK3CD (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL28897482 | 0.86 | SRC (0.82) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL23917421 | 0.84 | PIK3CD (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL3603461 | 0.84 | PIK3CD (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL3614419 | 0.83 | ABL1 (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL2434152 | 0.83 | SRC (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL2468132 | 0.81 | SRC (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL409057 | 0.81 | SRC (1.00) | ABL1SRCPIK3CDPIK3CAPIK3CB | |
| SCHEMBL3612706 | 0.81 | ABL1 (0.84) | ABL1SRCPIK3CDPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3728679-B1 | COLD ROLLED AND HEAT TREATED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ARCELORMITTAL (LU) | 2023-12-27 | — | — | EP | disclosed |
| US-20230340630-A1 | COLD ROLLED AND COATED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ARCELORMITTAL (LU) | 2023-10-26 | — | — | US | disclosed |
| EP-4217517-A1 | COLD ROLLED AND COATED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ArcelorMittal (LU) | 2023-08-02 | — | — | EP | disclosed |
| EP-4165222-A1 | COLD ROLLED AND HEAT-TREATED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ArcelorMittal (LU) | 2023-04-19 | — | — | EP | disclosed |
| US-20220340992-A1 | HEAT TREATED COLD ROLLED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ARCELORMITTAL (LU) | 2022-10-27 | — | — | US | disclosed |
| EP-4073281-A1 | HEAT TREATED COLD ROLLED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ArcelorMittal (LU) | 2022-10-19 | — | — | EP | disclosed |
| WO-2022064248-A1 | COLD ROLLED AND COATED STEEL SHEET AND A METHOD OF MANUFACTURING THEREOF | ARCELORMITTAL (LU) | 2022-03-31 | — | — | WO | disclosed |
| US-11266654-B2 | Apilimod compositions and methods for using same | AI Therapeutics, Inc. (US) | 2022-03-08 | — | — | US | disclosed |
| EP-3954375-A1 | APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER | AI Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11266654-B2 | Apilimod compositions and methods for using same | API5, HAAO, PDE3B | ABL1 1804/4885SRC 733/4885PIK3CD 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.